MetLife Investment Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Buy |
89,251
+21,290
| +31% | +$248K | 0.01% | 1292 |
|
|
2025
Q1 | $505K | Sell |
67,961
-1,015
| -1% | -$7.54K | ﹤0.01% | 1720 |
|
|
2024
Q4 | $414K | Buy |
68,976
+3,650
| +6% | +$21.9K | ﹤0.01% | 1904 |
|
|
2024
Q3 | $334K | Hold |
65,326
| – | – | ﹤0.01% | 1998 |
|
|
2024
Q2 | $236K | Buy |
65,326
+7,516
| +13% | +$27.2K | ﹤0.01% | 2143 |
|
|
2024
Q1 | $186K | Sell |
57,810
-456
| -0.8% | -$1.46K | ﹤0.01% | 2241 |
|
|
2023
Q4 | $286K | Hold |
58,266
| – | – | ﹤0.01% | 2033 |
|
|
2023
Q3 | $318K | Hold |
58,266
| – | – | ﹤0.01% | 1906 |
|
|
2023
Q2 | $391K | Hold |
58,266
| – | – | ﹤0.01% | 1862 |
|
|
2023
Q1 | $514K | Hold |
58,266
| – | – | ﹤0.01% | 1619 |
|
|
2022
Q4 | $445K | Hold |
58,266
| – | – | ﹤0.01% | 1711 |
|
|
2022
Q3 | $415K | Hold |
58,266
| – | – | ﹤0.01% | 1770 |
|
|
2022
Q2 | $471K | Buy |
58,266
+51,756
| +795% | +$419K | ﹤0.01% | 1709 |
|
|
2022
Q1 | $90.4K | Buy |
+6,510
| New | +$90.4K | ﹤0.01% | 2636 |
|